Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Czech TAVI Registry - rationale and design

Petr Kala, Milan Blaha

. 2012 ; 54 (5-6) : 230-234. [epub] 3 : e143-e150

Language English Country Czech Republic

Aortic stenosis is the most common type of valve disease in the adults. Until recently its treatment was an exclusive domain of cardiac surgery. At the same time the aortic valve replacement (SAVR) was not indicated in about 1/3 of the patients, though the prognosis of conservatively treated patients is very unfavourable with one-year mortality rate of 50%. These facts were the main reasons for starting a new interventional era of the aortic valve disease therapy in 2002 and from 2007 two types of valves fixed in stents have been commercially available. In the early phase the transcatheter aortic valve implantation (TAVI) was used just in patients with contraindication to SAVR or with high perioperative risk after surgery. Before applying this therapy to less risky patients some problems have to be solved: 1. clinical impact of the relatively high rate of paravalvular leaks and 2. long-term function of the implanted valve in follow-up exceeding 5 years. In the Czech Republic the first TAVI was performed in Prague, IKEM in December 2008. During a short period of time the TAVI programme was initiated also in other complex cardiovascular centres in Hradec Kralove, Brno, Prague—FN Kralovske Vinohrady and Trinec. Including the later starting centres (Usti n. Labem, Olomouc, Ceske Budejovice and other three centres in Prague—Nemocnice na Homolce, FN Motol and VFN) there is a total of 11 centres providing the TAVI at present. All centres except one (FN Motol) are part of the Czech TAVI Registry that was developed with the support of the Czech Society of Cardiology and started on 1 September, 2010. In general and more theoretically there are two parts of the Registry: 1. “Retrospective” including all the TAVI procedures from the beginning of the TAVI programme in the Czech Republic that was terminated on June 30, 2011 and 2. “Prospective” that has been following. Institute of Biostatistics and Analyses of Masaryk University takes care of the online and anonymized database. The results of the national Czech TAVI Registry should help to answer the clinical relevant questions mentioned above.

Obsahuje tabulky

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc12021219
003      
CZ-PrNML
005      
20170111131756.0
007      
ta
008      
120731s2012 xr f 000 0eng||
009      
AR
024    7_
$2 doi $a 10.1016/j.crvasa.2012.05.003
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng $b cze
044    __
$a xr
100    1_
$a Kala, Petr, $d 1965- $7 xx0043092 $u Department of Internal Medicine and Cardiology, Masaryk University and University Hospital Brno, Jihlavska 20, 625 00 Brno, Czech Republic
245    10
$a Czech TAVI Registry - rationale and design / $c Petr Kala, Milan Blaha
500    __
$a Obsahuje tabulky
504    __
$a Literatura $b 12
520    9_
$a Aortic stenosis is the most common type of valve disease in the adults. Until recently its treatment was an exclusive domain of cardiac surgery. At the same time the aortic valve replacement (SAVR) was not indicated in about 1/3 of the patients, though the prognosis of conservatively treated patients is very unfavourable with one-year mortality rate of 50%. These facts were the main reasons for starting a new interventional era of the aortic valve disease therapy in 2002 and from 2007 two types of valves fixed in stents have been commercially available. In the early phase the transcatheter aortic valve implantation (TAVI) was used just in patients with contraindication to SAVR or with high perioperative risk after surgery. Before applying this therapy to less risky patients some problems have to be solved: 1. clinical impact of the relatively high rate of paravalvular leaks and 2. long-term function of the implanted valve in follow-up exceeding 5 years. In the Czech Republic the first TAVI was performed in Prague, IKEM in December 2008. During a short period of time the TAVI programme was initiated also in other complex cardiovascular centres in Hradec Kralove, Brno, Prague—FN Kralovske Vinohrady and Trinec. Including the later starting centres (Usti n. Labem, Olomouc, Ceske Budejovice and other three centres in Prague—Nemocnice na Homolce, FN Motol and VFN) there is a total of 11 centres providing the TAVI at present. All centres except one (FN Motol) are part of the Czech TAVI Registry that was developed with the support of the Czech Society of Cardiology and started on 1 September, 2010. In general and more theoretically there are two parts of the Registry: 1. “Retrospective” including all the TAVI procedures from the beginning of the TAVI programme in the Czech Republic that was terminated on June 30, 2011 and 2. “Prospective” that has been following. Institute of Biostatistics and Analyses of Masaryk University takes care of the online and anonymized database. The results of the national Czech TAVI Registry should help to answer the clinical relevant questions mentioned above.
650    _2
$a databáze jako téma $7 D019992
650    _2
$a srdeční katetrizace $x dějiny $x metody $7 D006328
650    _2
$a aortální stenóza $x terapie $7 D001024
650    _2
$a chirurgická náhrada chlopně $x kontraindikace $x metody $x škodlivé účinky $7 D019918
650    _2
$a srdeční chlopně umělé $x statistika a číselné údaje $7 D006350
650    _2
$a lidé $7 D006801
650    _2
$a adresáře jako téma $7 D004181
651    _2
$a Česká republika $7 D018153
653    00
$a nemocní s vysokým operačním rizikem
653    00
$a registr
653    00
$a transkatetrová implantace aortální chlopně (TAVI)
700    1_
$a Blaha, Milan $7 xx0209712 $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic
773    0_
$t Cor et vasa $x 0010-8650 $g Roč. 54, č. 5-6 [3] (2012), s. 230-234 (e e143-e150) $w MED00010972
856    41
$u https://e-coretvasa.cz/pdfs/cor/2012/05/20.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 2980 $c 438 $y 2 $z 0
990    __
$a 20120731115810 $b ABA008
991    __
$a 20170111131854 $b ABA008
999    __
$a ok $b bmc $g 915428 $s 778501
BAS    __
$a 3
BMC    __
$a 2012 $b 54 $c 5-6 $g 3 $d 230-234 $f e143-e150 $i 0010-8650 $m Cor et Vasa (Brno) $n Cor Vasa (Brno Print) $x MED00010972
LZP    __
$a 2012-33/dkjč

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...